Key result
Minimally invasive surgical LV lead placement is linked to ~35 ms shorter QRS duration.
Why the study?
Transvenous insertion of left ventricular pacing leads via the coronary sinus is unsuccessful in 8-10% of patients requiring CRT, necessitating alternative approaches.
Does minimally invasive surgical LV lead placement safely and effectively accomplish cardiac resynchronization in patients with heart failure and failed transvenous lead insertion?
Observational (n=54)
Does minimally invasive surgical LV lead placement safely and effectively accomplish cardiac resynchronization in patients with heart failure and failed transvenous lead insertion?
Minimally invasive surgical LV lead placement is a safe and effective alternative for cardiac resynchronization therapy in patients with failed transvenous insertion.
Answers are grounded in this paper and cite their sources.
May support surgical LV lead placement after failed transvenous CRT; hypothesis-generating and warrants randomized trials before practice change.
BACKGROUND: : Cardiac resynchronization therapy (CRT) improves symptoms, quality of life, and ejection fraction in selected patients with congestive heart failure (CHF) and interventricular conduction delay. Transvenous insertion of left ventricular (LV) pacing leads via the coronary sinus is unsuccessful in 8-10% of patients. This study describes intermediate-term follow up of minimally invasive surgical techniques for CRT as a viable alternative after failed transvenous lead insertion. METHODS: : From March 2001 to October 2005, fifty-four patients with NYHA Class III-IV symptoms, QRS duration 181 ± 40 milliseconds, and LV ejection fraction 19.7 ± 8.0% underwent a total of 56 minimally invasive LV lead placements via thoracoscopic video assistance (n = 38) or minithoracotomy (n = 17). One patient required full thoracotomy after a previous video-assisted thoracoscopic procedure. Intraoperative transesophageal echocardiography was used to assess changes in LV function. RESULTS: : Acute thresholds for the active lead measured 1.10 ± 0.62 V, with R-wave amplitude of 12.3 ± 6.6 mV and impedance of 631 ± 185 Ohm. Thirty-day mortality was 5%. There were no perioperative myocardial infarctions or strokes. Five patients required transfusion, 3 had exacerbation of prior renal insufficiency, 5 had pulmonary complications, and 8 required inotropic support for more than 48 hours. Intermediate-term follow up (mean 20 ± 16 months, range 11 days to 55 months) revealed 3 patients with lead failure requiring additional surgical intervention. Hospitalization due to worsening CHF occurred in 5 patients, and 2 of these patients required intravenous inotropic support. QRS duration decreased to 146 ± 36 milliseconds postoperatively (P < 0.001). CONCLUSION: : Minimally invasive surgical lead placement safely and effectively accomplishes cardiac resynchronization using either thoracoscopic or minithoracotomy techniques.
No takes yet. Share an insight, caveat, or question.
Corvera et al. (2007) conducted an observational in Congestive heart failure with interventricular conduction delay (n=54). Minimally invasive surgical left ventricular lead placement was evaluated on QRS duration (p=<0.001). Minimally invasive surgical left ventricular lead placement safely achieved cardiac resynchronization, reducing QRS duration from 181 to 146 milliseconds.
Synapse has enriched 10 related papers. Consider them for comparative context: